Clinical Trials Directory

Trials / Completed

CompletedNCT00795054

The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family

The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family: A Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Center for International Blood and Marrow Transplant Research · Network
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this pilot study is to determine the feasibility of conducting a study of out-of-pocket costs and the long-term financial impact of allogeneic stem cell transplant.

Detailed description

Allogeneic hematopoietic stem cell transplantation (HSCT) is the indicated treatment for many life-threatening illnesses affecting both adults and children. Transplant recovery and late effects require long-term medical care. At the same time that the family faces a medical crisis, a resulting financial crisis may also be pending, but is often pushed to the background due to the necessity of first preserving life. A large proportion of patients undergoing HSCT incur significant financial burden from out-of-pocket costs and a decrease in household income. Predetermined variables, both medical and demographic, gathered at the pre-transplant clinical consultation have the potential to predict the patients at greatest financial risk. This study will describe both the out-of-pocket costs and the income changes that may result from HSCT to help patients and their caregivers have a clearer picture of these costs and develop a financial plan. Health care providers can utilize this information to better inform patients and connect them to resources.

Conditions

Interventions

TypeNameDescription
OTHERHousehold financial data collectionBaseline financial survey pre-transplant, financial diary post-transplant every two weeks for 3 months, and financial questionnaire via phone survey at 6, 12, 18 and 24 months post-transplant.

Timeline

Start date
2009-03-01
Primary completion
2012-09-01
Completion
2015-08-01
First posted
2008-11-21
Last updated
2015-10-06

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00795054. Inclusion in this directory is not an endorsement.